Clinical Trials Logo

Metabolic Syndrome clinical trials

View clinical trials related to Metabolic Syndrome.

Filter by:

NCT ID: NCT00657605 Completed - Obesity Clinical Trials

Effects of Human Leptin Replacement

Start date: June 2001
Phase: Phase 2
Study type: Interventional

This study will test the hypothesis that leptin contributes to the regulation of the dynamics of human endocrine function.

NCT ID: NCT00655902 Completed - Type 2 Diabetes Clinical Trials

Copenhagen Obesity Risk Assessment Study

COBRA
Start date: April 2008
Phase: N/A
Study type: Interventional

The aim of the present study is to assess the effect of a high intake of industrially produced trans fatty acids for 16 weeks on abdominal obesity and risk markers of type 2 diabetes and heart disease in healthy, moderately overweight, postmenopausal women.

NCT ID: NCT00654485 Completed - Metabolic Syndrome Clinical Trials

COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects

Start date: May 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy of treatment with rosuvastatin with atorvastatin in reducing Low density lipoprotein cholesterol over 6 weeks of treatment in subjects with metabolic syndrome.

NCT ID: NCT00645775 Completed - Obesity Clinical Trials

Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome

Start date: November 2006
Phase: N/A
Study type: Interventional

The study investigated the use and efficacy of the seeds of African bush mango (Irvingia gabonensis)to control body weight, blood lipids and hormones in overweight and obese people.

NCT ID: NCT00640783 Completed - Metabolic Syndrome Clinical Trials

Mediterranean Diet and the Metabolic Syndrome

Start date: June 2001
Phase: N/A
Study type: Interventional

The metabolic syndrome has been identified as a target for dietary therapies to reduce risk of cardiovascular disease; however, the role of diet in the etiology of the metabolic syndrome is poorly understood. To assess the effect of a Mediterranean-style diet on endothelial function and vascular inflammatory markers in patients with the metabolic syndrome Randomized, single-blind trial conducted from June 2001 to January 2004 at a university hospital in Italy among 180 patients (99 men and 81 women) with the metabolic syndrome, as defined by the Adult Treatment Panel III. Patients in the intervention group (n = 90) were instructed to follow a Mediterranean-style diet and received detailed advice about how to increase daily consumption of whole grains, fruits, vegetables, nuts, and olive oil; patients in the control group (n = 90) followed a prudent diet (carbohydrates, 50%-60%; proteins, 15%-20%; total fat, <30%). After 2 years, patients following the Mediterranean-style diet consumed more foods rich in monounsaturated fat, polyunsaturated fat, and fiber and had a lower ratio of omega-6 to omega-3 fatty acids. Total fruit, vegetable, and nuts intake (274 g/d), whole grain intake (103 g/d), and olive oil consumption (8 g/d) were also significantly higher in the intervention group (P<.001). The level of physical activity increased in both groups by approximately 60%, without difference between groups. Mean body weight decreased more in patients in the intervention group (-4.0 kg) than in those in the control group (-1.2 kg) (P<.001). Compared with patients consuming the control diet, patients consuming the intervention diet had significantly reduced serum concentrations of hs-CRP (P = .01), IL-6 (P = .04), IL-7 (P = 0.4), and IL-18 (P = 0.3), as well as decreased insulin resistance (P<.001). Endothelial function score improved in the intervention group but remained stable in the control group. At 2 years of follow-up, 40 patients in the intervention group still had features of the metabolic syndrome, compared with 78 patients in the control group (P<.001). A Mediterranean-style diet might be effective in reducing the prevalence of the metabolic syndrome and its associated cardiovascular risk.

NCT ID: NCT00640757 Completed - Metabolic Syndrome Clinical Trials

Methionine-Restriction Diet (MRD) in Obese Adults With Metabolic Syndrome

Start date: July 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if limiting dietary methionine (MET), one of the 10 essential amino acids (which make up proteins), causes weight loss and/or improves glucose metabolism.

NCT ID: NCT00640276 Completed - Metabolic Syndrome Clinical Trials

Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome

ProPit
Start date: April 2008
Phase: Phase 4
Study type: Interventional

We will identify the influence of long-term treatment of Pitavastatin compared to non-treatment control group on the metabolic syndrome by evaluation of a change of metabolic syndrome component score. And we will additionally observe the changes of CVD risk factors like lipid profile, abdominal fat, insulin resistance and so on.

NCT ID: NCT00639756 Completed - Metabolic Syndrome Clinical Trials

The Effect of Allopurinol on Insulin Resistance and Blood Pressure

Start date: June 2008
Phase: Phase 2
Study type: Interventional

Studies in animals have found that allopurinol can markedly improve fructose induced metabolic syndrome. In this study we test the hypothesis that allopurinol may lower BP, reduce triglycerides, and improve metabolic parameters in subjects placed on a high fructose diet.

NCT ID: NCT00636766 Completed - Stroke Clinical Trials

Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque

Start date: September 2005
Phase: N/A
Study type: Interventional

The aim of the present study is to examine the atherosclerotic plaque stability using in vivo and in vitro techniques and to investigate the influence of exercise, anti-diabetic, lipid-lowering and cannabinoids receptor antagonists on atherosclerotic plaque texture in patients with cardiovascular risk and animals prone to atherosclerosis.

NCT ID: NCT00636753 Suspended - Metabolic Syndrome Clinical Trials

Antipsychotics and Metabolic Syndrome

Start date: September 2008
Phase: N/A
Study type: Observational

The purpose of the study is to determine whether antipsychotic treatment is influence psychiatric patients due to endocrine and metabolic status and quality of life.